Hepatozelluläres Karzinom

Semela, David and Heim, Markus. (2011) Hepatozelluläres Karzinom. Therapeutische Umschau, Bd. 68, H. 4. pp. 213-217.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6007616

Downloads: Statistics Overview


HCC is the fifth most common tumor worldwide and the third cause of cancer-related deaths. The incidence of HCC is increasing. HCC has become the leading cause of death in patients with liver cirrhosis. Surveillance of patients with chronic liver disease allows early detection of HCC. Surgical resection, liver transplantation and ablative therapies can cure early stage HCC. HCC of intermediate and advanced stage can be treated by chemoembolisation and the tyrosine kinase inhibitor sorafenib, respectively, leading to improved survival. This review summarizes the recent diagnostic and therapeutic developments in the field of HCC.
Faculties and Departments:03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Hepatology Laboratory (Heim)
UniBasel Contributors:Heim, Markus H.
Item Type:Article, refereed
Article Subtype:Further Journal Contribution
Publisher:Hans Huber
Note:Note: Englischer Titel: Hepatocellular carcinoma -- Publication type according to Uni Basel Research Database: Journal item
Last Modified:24 May 2013 09:14
Deposited On:26 Apr 2013 06:56

Repository Staff Only: item control page